Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.46
CPTS's Cash to Debt is ranked lower than
133% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. CPTS: 1.46 )
Ranked among companies with meaningful Cash to Debt only.
CPTS' s 10-Year Cash to Debt Range
Min: 0.47  Med: 88.71 Max: No Debt
Current: 1.46
Equity to Asset 0.57
CPTS's Equity to Asset is ranked lower than
141% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. CPTS: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
CPTS' s 10-Year Equity to Asset Range
Min: 0.05  Med: 0.73 Max: 0.92
Current: 0.57
0.05
0.92
Interest Coverage 3.00
CPTS's Interest Coverage is ranked lower than
231% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 38.48 vs. CPTS: 3.00 )
Ranked among companies with meaningful Interest Coverage only.
CPTS' s 10-Year Interest Coverage Range
Min: 1  Med: 10000.00 Max: 1000
Current: 3
1
1000
F-Score: 7
Z-Score: 8.04
M-Score: -2.42
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 9.50
CPTS's Operating margin (%) is ranked lower than
134% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. CPTS: 9.50 )
Ranked among companies with meaningful Operating margin (%) only.
CPTS' s 10-Year Operating margin (%) Range
Min: -1575000  Med: -77.35 Max: 11.1
Current: 9.5
-1575000
11.1
Net-margin (%) 3.80
CPTS's Net-margin (%) is ranked lower than
134% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.58 vs. CPTS: 3.80 )
Ranked among companies with meaningful Net-margin (%) only.
CPTS' s 10-Year Net-margin (%) Range
Min: -1445300  Med: -73.55 Max: 58.3
Current: 3.8
-1445300
58.3
ROE (%) 3.10
CPTS's ROE (%) is ranked lower than
139% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. CPTS: 3.10 )
Ranked among companies with meaningful ROE (%) only.
CPTS' s 10-Year ROE (%) Range
Min: -145.1  Med: -53.65 Max: 54.1
Current: 3.1
-145.1
54.1
ROA (%) 2.20
CPTS's ROA (%) is ranked lower than
131% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. CPTS: 2.20 )
Ranked among companies with meaningful ROA (%) only.
CPTS' s 10-Year ROA (%) Range
Min: -102.5  Med: -44.05 Max: 32.7
Current: 2.2
-102.5
32.7
ROC (Joel Greenblatt) (%) 38.40
CPTS's ROC (Joel Greenblatt) (%) is ranked lower than
133% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. CPTS: 38.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CPTS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -40912.3  Med: -133.40 Max: 72.2
Current: 38.4
-40912.3
72.2
Revenue Growth (3Y)(%) 0.60
CPTS's Revenue Growth (3Y)(%) is ranked lower than
161% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. CPTS: 0.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CPTS' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: 41.70 Max: 99
Current: 0.6
0
99
EBITDA Growth (3Y)(%) 1.20
CPTS's EBITDA Growth (3Y)(%) is ranked lower than
188% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. CPTS: 1.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CPTS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -22.8  Med: -2.70 Max: 22.1
Current: 1.2
-22.8
22.1
EPS Growth (3Y)(%) -10.60
CPTS's EPS Growth (3Y)(%) is ranked lower than
192% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. CPTS: -10.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CPTS' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -16.80 Max: 22.5
Current: -10.6
0
22.5
» CPTS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

CPTS Guru Trades in

CPTS Guru Trades in

CPTS Guru Trades in

Q2 2013

CPTS Guru Trades in Q2 2013

Mario Gabelli 1,194,420 sh (New)
PRIMECAP Management Sold Out
RS Investment Management Sold Out
Steven Cohen Sold Out
Jim Simons Sold Out
Pioneer Investments Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with CPTS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 110.70
CPTS's P/E(ttm) is ranked lower than
220% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.30 vs. CPTS: 110.70 )
Ranked among companies with meaningful P/E(ttm) only.
CPTS' s 10-Year P/E(ttm) Range
Min: 4.25  Med: 81.33 Max: 1582
Current: 110.7
4.25
1582
PE(NRI) 110.70
CPTS's PE(NRI) is ranked lower than
216% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.10 vs. CPTS: 110.70 )
Ranked among companies with meaningful PE(NRI) only.
CPTS' s 10-Year PE(NRI) Range
Min: 0  Med: 0.00 Max: 0
Current: 110.7
P/B 5.80
CPTS's P/B is ranked lower than
142% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.81 vs. CPTS: 5.80 )
Ranked among companies with meaningful P/B only.
CPTS' s 10-Year P/B Range
Min: 2.05  Med: 8.64 Max: 36.17
Current: 5.8
2.05
36.17
P/S 7.14
CPTS's P/S is ranked lower than
128% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.79 vs. CPTS: 7.14 )
Ranked among companies with meaningful P/S only.
CPTS' s 10-Year P/S Range
Min: 2.45  Med: 13.32 Max: 1752
Current: 7.14
2.45
1752
PFCF 48.40
CPTS's PFCF is ranked lower than
293% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.93 vs. CPTS: 48.40 )
Ranked among companies with meaningful PFCF only.
CPTS' s 10-Year PFCF Range
Min: 17.54  Med: 48.52 Max: 2220
Current: 48.4
17.54
2220
EV-to-EBIT 47.60
CPTS's EV-to-EBIT is ranked lower than
205% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.92 vs. CPTS: 47.60 )
Ranked among companies with meaningful EV-to-EBIT only.
CPTS' s 10-Year EV-to-EBIT Range
Min: 24.5  Med: 53.00 Max: 634.6
Current: 47.6
24.5
634.6
PEG 7.00
CPTS's PEG is ranked lower than
369% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.80 vs. CPTS: 7.00 )
Ranked among companies with meaningful PEG only.
CPTS' s 10-Year PEG Range
Min: 0  Med: 1.23 Max: 24.83
Current: 7
0
24.83
Shiller P/E 70.70
CPTS's Shiller P/E is ranked lower than
300% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.27 vs. CPTS: 70.70 )
Ranked among companies with meaningful Shiller P/E only.
CPTS' s 10-Year Shiller P/E Range
Min: 45.36  Med: 58.32 Max: 135.82
Current: 70.7
45.36
135.82
Current Ratio 5.78
CPTS's Current Ratio is ranked lower than
138% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. CPTS: 5.78 )
Ranked among companies with meaningful Current Ratio only.
CPTS' s 10-Year Current Ratio Range
Min: 0  Med: 0.00 Max: 0
Current: 5.78
Quick Ratio 2.14
CPTS's Quick Ratio is ranked lower than
138% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. CPTS: 2.14 )
Ranked among companies with meaningful Quick Ratio only.
CPTS' s 10-Year Quick Ratio Range
Min: 0  Med: 0.00 Max: 0
Current: 2.14

Valuation & Return

vs
industry
vs
history
Price/Net Cash 1034.00
CPTS's Price/Net Cash is ranked lower than
558% of the 43 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.27 vs. CPTS: 1034.00 )
Ranked among companies with meaningful Price/Net Cash only.
CPTS' s 10-Year Price/Net Cash Range
Min: 3.5  Med: 12.20 Max: 700
Current: 1034
3.5
700
Price/Net Current Asset Value 50.90
CPTS's Price/Net Current Asset Value is ranked lower than
222% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.86 vs. CPTS: 50.90 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
CPTS' s 10-Year Price/Net Current Asset Value Range
Min: 26.3  Med: 54.10 Max: 164.1
Current: 50.9
26.3
164.1
Price/Tangible Book 7.30
CPTS's Price/Tangible Book is ranked lower than
163% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. CPTS: 7.30 )
Ranked among companies with meaningful Price/Tangible Book only.
CPTS' s 10-Year Price/Tangible Book Range
Min: 3.2  Med: 8.70 Max: 56.4
Current: 7.3
3.2
56.4
Price/Projected FCF 5.10
CPTS's Price/Projected FCF is ranked lower than
264% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. CPTS: 5.10 )
Ranked among companies with meaningful Price/Projected FCF only.
CPTS' s 10-Year Price/Projected FCF Range
Min: 2.7  Med: 3.80 Max: 11.1
Current: 5.1
2.7
11.1
Price/Median PS Value 0.50
CPTS's Price/Median PS Value is ranked lower than
148% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.26 vs. CPTS: 0.50 )
Ranked among companies with meaningful Price/Median PS Value only.
CPTS' s 10-Year Price/Median PS Value Range
Min: 0.2  Med: 0.90 Max: 59
Current: 0.5
0.2
59
Price/Graham Number 7.90
CPTS's Price/Graham Number is ranked lower than
279% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. CPTS: 7.90 )
Ranked among companies with meaningful Price/Graham Number only.
CPTS' s 10-Year Price/Graham Number Range
Min: 1  Med: 5.30 Max: 11
Current: 7.9
1
11
Earnings Yield (Greenblatt) (%) 2.10
CPTS's Earnings Yield (Greenblatt) (%) is ranked lower than
134% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. CPTS: 2.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CPTS' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.2  Med: 1.90 Max: 4.1
Current: 2.1
0.2
4.1
Forward Rate of Return (Yacktman) (%) 0.30
CPTS's Forward Rate of Return (Yacktman) (%) is ranked lower than
270% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.07 vs. CPTS: 0.30 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CPTS' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -7.6  Med: -2.00 Max: 0.6
Current: 0.3
-7.6
0.6

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK